1 Instituto de Investigaciones Biomédicas Alberto Sols (Centro Mixto CSIC-UAM) , Madrid, Spain .
2 Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERdem), Instituto de Salud Carlos III , Madrid, Spain .
Antioxid Redox Signal. 2018 May 1;28(13):1187-1208. doi: 10.1089/ars.2017.7373. Epub 2017 Dec 11.
Sirtuin 1 (SIRT1) is a key player in liver physiology and a therapeutic target against hepatic inflammation. We evaluated the role of SIRT1 in the proinflammatory context and oxidative stress during acetaminophen (APAP)-mediated hepatotoxicity.
SIRT1 protein levels decreased in human and mouse livers following APAP overdose. SIRT1-Tg mice maintained higher levels of SIRT1 on APAP injection than wild-type mice and were protected against hepatotoxicity by modulation of antioxidant systems and restrained inflammatory responses, with decreased oxidative stress, proinflammatory cytokine messenger RNA levels, nuclear factor kappa B (NFκB) signaling, and cell death. Mouse hepatocytes stimulated with conditioned medium of APAP-treated macrophages (APAP-CM) showed decreased SIRT1 levels; an effect mimicked by interleukin (IL)1β, an activator of NFκB. This negative modulation was abolished by neutralizing IL1β in APAP-CM or silencing p65-NFκB in hepatocytes. APAP-CM of macrophages from SIRT1-Tg mice failed to downregulate SIRT1 protein levels in hepatocytes. In vivo administration of the NFκB inhibitor BAY 11-7082 preserved SIRT1 levels and protected from APAP-mediated hepatotoxicity.
Our work evidenced the unique role of SIRT1 in APAP hepatoprotection by targeting oxidative stress and inflammation.
SIRT1 protein levels are downregulated by IL1β/NFκB signaling in APAP hepatotoxicity, resulting in inflammation and oxidative stress. Thus, maintenance of SIRT1 during APAP overdose by inhibiting NFκB might be clinically relevant. Rebound Track: This work was rejected during standard peer review and rescued by Rebound Peer Review (Antioxid Redox Signal 16:293-296, 2012) with the following serving as open reviewers: Rafael de Cabo, Joaquim Ros, Kalervo Hiltunen, and Neil Kaplowitz. Antioxid. Redox Signal. 28, 1187-1208.
沉默信息调节因子 1(SIRT1)是肝脏生理学中的关键因子,也是针对肝炎症的治疗靶点。我们评估了 SIRT1 在乙酰氨基酚(APAP)介导的肝毒性中促炎环境和氧化应激中的作用。
APAP 过量后,人肝和鼠肝中的 SIRT1 蛋白水平降低。与野生型小鼠相比,SIRT1-Tg 小鼠在注射 APAP 后维持更高水平的 SIRT1,并通过调节抗氧化系统和抑制炎症反应来防止肝毒性,其表现为氧化应激、促炎细胞因子信使 RNA 水平、核因子 kappa B(NFκB)信号和细胞死亡减少。用 APAP 处理的巨噬细胞条件培养基(APAP-CM)刺激的鼠肝细胞显示 SIRT1 水平降低;这一效应可被 NFκB 的激活物白细胞介素(IL)1β模拟。在 APAP-CM 中中和 IL1β 或在肝细胞中沉默 p65-NFκB 可消除这种负调节。来自 SIRT1-Tg 小鼠的巨噬细胞的 APAP-CM 未能下调肝细胞中的 SIRT1 蛋白水平。体内给予 NFκB 抑制剂 BAY 11-7082 可维持 SIRT1 水平并防止 APAP 介导的肝毒性。
我们的工作证明了 SIRT1 在通过靶向氧化应激和炎症来保护 APAP 肝损伤方面的独特作用。
IL1β/NFκB 信号在 APAP 肝毒性中下调 SIRT1 蛋白水平,导致炎症和氧化应激。因此,通过抑制 NFκB 在 APAP 过量时维持 SIRT1 可能具有临床相关性。